Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Bogus HIV tests

This article was originally published in The Gray Sheet

Executive Summary

Federal Trade Commission charges David Rothbart, doing business as Medimax, Inc., with falsely representing on the Internet that his tests accurately detect HIV. At the request of the FTC, a federal district court in Orlando, Florida has issued a temporary restraining order against Rothbart. The agency's complaint seeks to permanently enjoin Rothbart and require payment of "consumer redress." Separately, Cyberlinx Marketing settled FTC charges earlier this month that the Internet company falsely represented its HIV home test kits as accurately detecting HIV. Under the stipulated final settlement order, Cyberlinx and its president, Jeffrey Stein, are banned from marketing HIV home test kits and must reimburse the money received from the sale of the kits

You may also be interested in...

Bogus HIV tests

Alfa Scientific Designs is charged by the Federal Trade Commission with falsely representing that its Alfa HIV-1/2 Rapid Tests accurately detect HIV in its third legal action to date against a marketer of HIV tests. San Diego-based Alfa supplied the faulty HIV tests to Medimax, Inc., which was charged by the FTC in December for falsely representing on the Internet that its HIV tests accurately detected the disease (1"The Gray Sheet" Dec. 6, p. 24). On Nov. 17, FTC announced a settlement of charges against Las Vegas-based Cyberlinx Marketing related to claims over the Internet that its tests accurately detected HIV, including a ban from marketing any HIV test kits and repayment of sales proceeds. Alfa has agreed to a stipulated preliminary injunction that will halt all sales of its HIV tests. The complaint and stipulated preliminary injunction were filed Jan. 13 in the U.S. District Court for the Southern District of California

Hikma Adds Sesen’s Vicineum To MENA Brands

Hikma and Sesen Bio have struck a deal that will see Hikma distribute the Vicineum brand in the MENA region.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts